Skip to content
QUICKI Calculator
Calculate your Quantitative Insulin Sensitivity Check Index (QUICKI) instantly from fasting glucose and insulin — with clinical interpretation, HOMA-IR comparison, and personalised metabolic insights.
Enter your fasting lab values. Both glucose units are supported — select your unit before entering values.
—
—
What Is the QUICKI Calculator and What Does It Measure?
The QUICKI calculator computes the Quantitative Insulin Sensitivity Check Index — a clinically validated, mathematically derived measure of how effectively your body responds to insulin. Introduced by Katz et al. in 2000 in the Journal of Clinical Endocrinology & Metabolism, QUICKI uses just two fasting blood test values — plasma glucose (mg/dL) and serum insulin (µU/mL) — to produce a dimensionless score that correlates strongly with the gold-standard hyperinsulinemic-euglycemic glucose clamp technique, which is expensive, invasive, and practically available only in research settings.
The QUICKI score is inversely related to insulin resistance. A higher score means your cells are responding efficiently to insulin, clearing glucose from the bloodstream without requiring excessive insulin production. A lower score signals that cells are resistant to insulin’s signalling, forcing the pancreas to produce more and more insulin to achieve the same glucose-lowering effect — a hallmark of prediabetes, metabolic syndrome, and type 2 diabetes.
Unlike a simple fasting glucose test that tells you whether blood sugar is elevated, QUICKI tells you why it may be elevated — or gives early warning that insulin resistance is developing before glucose levels become overtly abnormal. This makes it an invaluable tool for metabolic risk assessment, preventive health monitoring, and clinical research.
The QUICKI Formula: How Insulin Sensitivity Is Calculated
QUICKI is derived from a logarithmic transformation of fasting insulin and glucose values. The use of logarithms is deliberate — it linearises the relationship between these variables, making the resulting index more uniformly distributed across a wide range of metabolic states and more directly comparable between patients.
QUICKI = 1 ÷ [log₁₀(Fasting Insulin µU/mL) + log₁₀(Fasting Glucose mg/dL)] For mmol/L: Convert glucose first → mg/dL = mmol/L × 18.018Base-10 logarithm is standard. Insulin must be in µU/mL (equivalent to mIU/L numerically). Glucose must be in mg/dL; our calculator automatically converts mmol/L inputs. Both values must be from a single coordinated fasting sample.
Understanding the Mathematics Intuitively
The formula uses reciprocal notation (1 divided by) to invert the relationship. Without the inversion, higher glucose and insulin would produce a higher raw number — which would suggest worse sensitivity is better. By taking the reciprocal, we ensure that higher QUICKI scores always mean better insulin sensitivity, matching clinical intuition.
The logarithm base-10 transformation compresses the wide range of glucose and insulin values into a manageable mathematical space where the index is approximately normally distributed in healthy populations. This is why QUICKI has superior statistical properties compared to simple ratio indices like the glucose-to-insulin ratio.
QUICKI Reference Ranges: How to Interpret Your Score
QUICKI scores exist on a continuous scale from approximately 0.20 (severe insulin resistance) to 0.50+ (high sensitivity, typical in lean, physically active individuals). The clinically meaningful thresholds from the original validation research and subsequent population studies are as follows:
| QUICKI Score | Classification | Clinical Meaning | Typical Population |
|---|---|---|---|
| > 0.45 | High Sensitivity | Excellent insulin action; cells highly responsive | Lean, physically fit, young adults |
| 0.34 – 0.44 | Normal Sensitivity | Adequate insulin response; low metabolic risk | Most healthy adults with normal BMI |
| 0.30 – 0.33 | Reduced / Borderline | Early signs of resistance; lifestyle intervention warranted | Overweight adults, sedentary lifestyle, family history |
| < 0.30 | Insulin Resistant | Significant resistance; elevated risk of metabolic disease | Obesity, prediabetes, metabolic syndrome, PCOS |
It is important to note that these thresholds represent population-level patterns from validation studies and may vary slightly between different ethnic groups, age ranges, and laboratory assay methods. Reference ranges in Asian populations, for instance, may be shifted — some studies suggest insulin resistance patterns at higher QUICKI values compared to Western reference populations. Always interpret results in consultation with your clinical provider who understands your full health context.
QUICKI vs. HOMA-IR: Understanding the Two Most Used Insulin Sensitivity Indices
QUICKI and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) are the two most widely used surrogate indices for estimating insulin sensitivity from fasting blood tests. They are derived from the same two variables — fasting glucose and fasting insulin — but use different mathematical approaches. Understanding their differences helps you know when each is more appropriate and how to interpret conflicting results.
| Feature | QUICKI | HOMA-IR |
|---|---|---|
| Formula | 1 ÷ [log(Insulin) + log(Glucose)] | (Insulin × Glucose) ÷ 22.5* |
| Direction | Higher = more sensitive | Higher = more resistant |
| Mathematical relationship to clamp | Linear (better fit at extremes) | Non-linear (weaker at high resistance) |
| Normal range | 0.34–0.45 | 1.0–2.5 (lab-dependent) |
| Best at detecting | Sensitivity across full range | Moderate resistance patterns |
| Research usage | Epidemiology, clinical screening | Epidemiology, clinical, very widely cited |
| Limitations | Assay-dependent; not for T1DM | Non-linear; less precise at high resistance |
*HOMA-IR formula adjusted for SI units. Standard formula: (fasting insulin µU/mL × fasting glucose mg/dL) ÷ 405.
The key mathematical advantage of QUICKI over HOMA-IR is its approximately linear relationship with glucose clamp-measured insulin sensitivity across the full range of metabolic states — from highly insulin-sensitive lean individuals to severely resistant obese patients with type 2 diabetes. HOMA-IR’s relationship with clamp measurements becomes non-linear at the extremes, making it less reliable in very high or very low resistance scenarios. Many researchers use both indices in parallel, as they provide complementary perspectives.
What Causes Low QUICKI Scores? The Root Drivers of Insulin Resistance
A low QUICKI score signals that your cells are not responding normally to insulin’s signal to take up glucose from the bloodstream. This insulin resistance is not a single disease — it is a physiological state driven by multiple interconnected factors, many of which are modifiable through lifestyle changes.
Excess Body Fat, Especially Visceral Fat
Visceral adipose tissue — the fat stored deep in the abdominal cavity around the organs — is metabolically active and releases inflammatory cytokines and free fatty acids that directly interfere with insulin signalling at the cellular level. The waist circumference is a better predictor of insulin resistance risk than overall BMI because it better reflects visceral fat accumulation. Individuals with normal BMI but elevated waist-to-hip ratios frequently show reduced QUICKI scores.
Physical Inactivity
Skeletal muscle is the primary site of insulin-stimulated glucose uptake, accounting for approximately 80% of postprandial glucose disposal. Physical inactivity causes skeletal muscle to down-regulate the GLUT4 glucose transporters that insulin activates, directly impairing insulin sensitivity. Even a single bout of moderate aerobic exercise transiently increases insulin sensitivity by 16–40% through mechanisms that bypass insulin signalling pathways, explaining why regular exercise is the most evidence-based intervention for improving QUICKI scores.
Dietary Patterns
Chronic consumption of ultra-processed foods, refined carbohydrates, and added sugars chronically elevates blood glucose and insulin levels, gradually desensitising insulin receptors. Conversely, dietary patterns high in fibre, polyphenols (found in vegetables, berries, and legumes), omega-3 fatty acids, and healthy fats have demonstrated improvements in insulin sensitivity markers including QUICKI in multiple randomised controlled trials.
Sleep Deprivation and Circadian Disruption
Even a single week of partial sleep deprivation (5–6 hours per night) can reduce insulin sensitivity by 20–25% in healthy adults, reflected in measurable QUICKI score decreases. Shift work, social jet lag, and irregular sleep schedules produce chronic circadian disruption that impairs glucose metabolism through multiple hormonal pathways including cortisol, growth hormone, and melatonin.
Chronic Psychological Stress
Elevated cortisol from chronic stress counteracts insulin signalling by promoting hepatic glucose production, stimulating lipolysis (releasing free fatty acids into circulation), and directly inhibiting GLUT4 expression in muscle tissue. The physiological connection between chronic stress and metabolic syndrome is well-established and mediated significantly through cortisol’s anti-insulin effects.
Genetic Predisposition and Ethnicity
Insulin resistance has a substantial hereditary component. First-degree relatives of individuals with type 2 diabetes show measurably lower QUICKI scores even at normal body weight and glucose levels. Additionally, certain ethnic groups — South Asian, East Asian, Hispanic, and Aboriginal populations — develop insulin resistance at lower BMI thresholds than Northern European populations, making QUICKI screening particularly valuable in these groups even when BMI appears normal.
Conditions Associated with Low QUICKI Scores
A reduced QUICKI score is not just a precursor to diabetes — it is associated with a broad constellation of metabolic conditions that share insulin resistance as a common underlying mechanism:
- Prediabetes and Type 2 Diabetes: QUICKI was specifically validated against type 2 diabetes pathophysiology. Declining QUICKI scores often precede fasting glucose abnormalities by years.
- Metabolic Syndrome: The cluster of hypertension, central obesity, dyslipidaemia, and elevated fasting glucose is directly mediated by insulin resistance, reliably reflected in low QUICKI scores.
- Polycystic Ovary Syndrome (PCOS): Up to 70% of women with PCOS demonstrate insulin resistance regardless of body weight. QUICKI is used in PCOS research as a primary outcome measure for insulin-sensitising interventions.
- Non-Alcoholic Fatty Liver Disease (NAFLD): Hepatic insulin resistance is central to NAFLD pathogenesis. QUICKI scores are inversely correlated with liver fat content and NAFLD severity.
- Cardiovascular Disease: Insulin resistance independently increases cardiovascular risk through promoting atherogenic dyslipidaemia (elevated triglycerides, low HDL), endothelial dysfunction, and chronic low-grade inflammation.
- Thyroid Dysfunction: Both hypothyroidism and hyperthyroidism can affect insulin sensitivity and QUICKI scores through distinct hormonal mechanisms.
Read the Original QUICKI Research Paper
Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity in Humans. J Clin Endocrinol Metab. 2000;85(7):2402–2410. The foundational paper that introduced, validated, and defined the clinical interpretation ranges for QUICKI.
Read on PubMed →How to Improve Your QUICKI Score: Evidence-Based Strategies
Unlike fixed risk factors such as genetics and age, insulin sensitivity is highly responsive to lifestyle interventions. The following strategies have demonstrated measurable improvement in QUICKI scores and equivalent insulin sensitivity markers in peer-reviewed clinical trials.
Resistance Training and Aerobic Exercise
Combining resistance training (which increases muscle mass and GLUT4 expression) with aerobic exercise (which acutely enhances insulin signalling for 24–48 hours post-exercise) produces the most robust improvements in insulin sensitivity. Meta-analyses show that structured exercise programmes of 150+ minutes per week improve HOMA-IR by 20–30% and produce equivalent QUICKI improvements. The benefit is dose-dependent — more consistent, vigorous exercise produces greater improvements.
Reducing Visceral Fat Through Caloric Deficit
Even modest weight loss of 5–10% of body weight produces disproportionate improvements in insulin sensitivity when that loss includes visceral fat reduction. This is because visceral fat reduction rapidly decreases the free fatty acid and inflammatory cytokine load that impairs insulin receptor function. Intermittent fasting and time-restricted eating patterns have shown particular efficacy in reducing visceral adiposity and improving fasting insulin levels.
Dietary Quality Improvements
The Mediterranean diet pattern — high in olive oil, vegetables, legumes, fish, and moderate in whole grains and wine — has the strongest evidence base for improving insulin sensitivity markers. Key mechanisms include high fibre content (slowing glucose absorption), polyphenols (improving insulin signalling pathways), and healthy fats (reducing inflammatory cytokine production). Specific foods with strong insulin-sensitising evidence include cinnamon, berberine, and green leafy vegetables.
Sleep Optimisation
Consistently achieving 7–9 hours of quality sleep per night and maintaining a regular sleep-wake schedule improves insulin sensitivity through cortisol normalisation, growth hormone pulsatility restoration, and reduced inflammatory signalling. Sleep apnoea treatment in affected individuals produces measurable HOMA-IR and QUICKI improvements comparable to moderate exercise interventions.
